Skip to content

AcrySof IQ ReSTOR Posterior Chamber Intraocular Lens, Models MA60D3 and SA60D3

by Alcon Research, Ltd.

PMA P040020

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None ongoing

2 closed

Documents

PMA P040020↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP040020 Date21 Mar 2005ApprovedStatusActive

Recalls

2 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-0429-2007 FDA Unclassified (pre-2012) initiated 14 Dec 2006
    • Terminated Z-0430-2007 FDA Unclassified (pre-2012) initiated 14 Dec 2006

    Intraocular lenses exposed to extreme temperatures while in storage.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
AcrySof IQ ReSTOR Posterior Chamber Intraocular Lens
Trade Name
Acrysof Restor Apodized Diffractive Optic Posterior Chamber IOL
Generic Name
Lens, multifocal intraocular
PMA Number
FDA Product Code
MFK
Device Class
Class III
Regulation
21 CFR Part 886.3600
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The AcrySof IQ ReSTOR Posterior Chamber Intraocular Lens is a multifocal intraocular lens designed for the visual correction of aphakia following cataractous lens removal in adult patients. It provides near, intermediate, and distance vision with enhanced spectacle independence, intended for placement within the capsular bag.

This device is supplied sterile and intended for single-use. It is classified as a Class III medical device under FDA regulations and requires a Premarket Approval (PMA) application. The lens is manufactured by Alcon Research, Ltd., and is distributed with specific model references (MA60D3 and SA60D3) for precise identification and use in ophthalmic surgical procedures.

Other devices from Alcon Research, Ltd.

See all devices from Alcon Research, Ltd. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of vision correction does this intraocular lens provide, and who is it intended for?

    The AcrySof IQ ReSTOR Posterior Chamber Intraocular Lens is designed to correct aphakia (the absence of a natural lens) after cataract removal in adult patients. It offers multifocal vision correction, enabling clear vision at near, intermediate, and distance ranges while increasing spectacle independence. This makes it ideal for patients who desire reduced reliance on glasses for various activities.

  • How is this lens supplied, and is it reusable?

    The AcrySof IQ ReSTOR lens is supplied sterile and is explicitly intended for single-use only. This ensures patient safety and reduces the risk of infection or contamination during surgical procedures.

  • What model references should I look for when ordering this device?

    This lens is available under specific model references: MA60D3 and SA60D3. These identifiers help ensure you select the correct lens for your surgical needs, as they are tailored for precise placement within the capsular bag.

  • What regulatory pathway was followed for this device, and how does that affect its use?

    The AcrySof IQ ReSTOR lens underwent a Premarket Approval (PMA) process through the FDA, as it is classified as a Class III medical device. This rigorous review confirms its safety and effectiveness for the intended use—correcting aphakia with multifocal vision correction—ensuring compliance with strict regulatory standards before clinical use.